Cardiovascular effects of bretylium tosylate in acute myocardial infarction.
D000208:Acute Disease; D000368:Aged; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001919:Bradycardia / Q000139:chemically induced; D001949:Bretylium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D002302:Cardiac Output / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002415:Cats; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007022:Hypotension / Q000139:chemically induced; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D010210:Papillary Muscles / Q000187:drug effects; D013610:Tachycardia / Q000139:chemically induced; D014105:Tosyl Compounds / Q000008:administration & dosage / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D001949:Bretylium Compounds; D002395:Catecholamines; D014105:Tosyl Compounds